During the past decade, Clinique Marzet conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Marzet" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Marzet" are "Non Small Cell Lung Cancer" (2 trials), "Colorectal Cancer" (1 trials), "Hematological Malignancy" (1 trials), "Lymphoma" (1 trials) and "Solid Tumor" (1 trials). Many other conditions were trialed in "Clinique Marzet" in a lesser frequency.

Most popular intervention types in "Clinique Marzet" are "Drug" (2 trials), "Genetic" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AMA (Assistance for ambulatory patients)" (1 trials), "Avelumab" (1 trials), "ICI treatment continuation" (1 trials), "ICI treatment discontinuation" (1 trials) and "Liquid biopsy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Marzet" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Clinique Marzet". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Clinique Marzet, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Marzet, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".